Regeneron aims for COVID-19 drug trials by early summer

Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials

Regeneron, Sanofi release preliminary results for Kevzara drug trial

Regeneron reports antibody treatment is less effective against omicron variant

Using Regeneron cocktail to treat Trump was a wholly appropriate call: Dr. Gottlieb

Regeneron president on Covid antibody cocktail efficacy and supply chain

Cramer: Don't buy Regeneron stock just because Trump says its coronavirus antibody cocktail works

Cramer's lightning round: Buy Regeneron stock here

Regeneron CEO: Choice, not price best for patients